Other Targets

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC22802	MK2-IN-28	A potent and selective, non-ATP competitive, allosteric MAPKAPK2/3 (MK2/3) inhibitor with IC50 of 8 nM for MK2, hTNFα EC50 of 0.31 uM. More description
DC22978	PF-04471141 hydrochloride	A potent and selective, CNS-penetrant PDE1 inhibitor with IC50 of 35 nM for PDE1B.. More description
DC22979	PF-04822163	A potent and selective, CNS-penetrant PDE1 inhibitor with IC50 of 2.4 nM for PDE1B.. More description
DC23521	VU 6010572	A potent and selective, CNS penetrant mGlu3 negative allosteric modulator with IC50 of 245 nM. More description
DC23520	VU 6001966	A potent and selective, CNS penetrant mGlu2 negative allosteric modulator with IC50 of 78 nM. More description
DC22885	TAN-67 dihydrobromide	A potent and selective δ-opioid receptor agonist that has high affinity and selectivity for the δ1 subtype with Ki of 1.12 nM. More description
DC20627	ABT 089 dihydrochloride	A potent and selective α4β2 nAChR agonist with Ki of 16 nM. More description
DC25087	Vandetanib trifluoroacetate	A potent and selective VEGFR2 (KDR) inhibitor with IC50 of 40 nM. More description
DC23839	IN-1233 phosphate	A potent and selective TGF-βRI (ALK5) inhibitor with IC50 of 34 nM, prevents tissue hyperplasia in the rat urethra or common iliac artery.. More description
DC23840	IN-1233	A potent and selective TGF-βRI (ALK5) inhibitor with IC50 of 34 nM, prevents tissue hyperplasia in the rat urethra or common iliac artery.. More description
DC22715	RP-67580	A potent and selective tachykinin NK1 receptor antagonist with Ki of 2.9 nM. More description
DC24175	A-770041	A potent and selective small-molecule inhibitor of Lck with IC50 of 147 nM. More description
DC22341	H-1152	A potent and selective ROCK inhibitor with Ki of 1.6 nM. More description
DC26074	CD 1530	A potent and selective RARγ receptor agonist with Ki of 150 nM. More description
DC22968	TC-E 5005	A potent and selective PDE10A inhibitor with IC50 of 7.28 nM. More description
DC22970	BMS 843496	A potent and selective PDE10A inhibitor with binding affinity (Kd) of 0.15 nM, IC50 of 2.11 nM. More description
DC22671	Saredutant	A potent and selective non-peptide antagonist of the neurokinin A (NK2) receptor. More description
DC20474	Nek2 inhibitor (R)-21	A potent and selective NIMA-related Kinase 2 (NEK2) inhibitor with IC50 of 22 nM, >200-fold selectivity over Plk1, Mps1, Aurora A and CDK2. More description
DC23966	mTOR-IN-1	A potent and selective mTOR inhibitor with Ki of 1.5 nM. More description
DC22887	THIQ	A potent and selective melanocortin 4 receptor (MC4R) agonist with EC50 of 2.1 nM. More description
DC23410	BI 186908	A potent and selective MCH-R1 antagonist with IC50 of 22 nM, Ki of 14 nM. More description
DC22707	Ibodutant	A potent and selective linear tachykinin NK2 receptor antagonist with pKb of 9.3. More description
DC26102	TK05	A potent and selective inhibitors of leukotriene C4 synthase (LTC4S) with IC50 of 95 nM, Ki of 6 nM. More description
DC23278	AM-7209	A potent and selective inhibitor of the MDM2-p53 interaction with Kd of 38 pM, and IC50 of 1.6 nM. More description
DC22973	UK-414495	A potent and selective inhibitor of neutral endopeptidase (NEP) with IC50 of 18.9 nM for hNEP. More description
DC24124	TH-588 hydrochloride	A potent and selective inhibitor of MTH1 protein with IC50 of 5 nM. More description
DC20590	Cortistatin A	A potent and selective inhibitor of mediator-associated kinase CDK8 (IC50=12 nM) and its paralogue CDK19. More description
DC22992	NSC95682	A potent and selective inhibitor of IRE1 endoribonuclease with IC50 of 0.41 uM. More description
DC22509	DPC-681	A potent and selective inhibitor of HIV-1 protease with IC90 of 4-40 nM. More description
DC22813	OXA-11	A potent and selective inhibitor of FAK phosphorylation with biochemical IC50 of 1.2 pM (pFAK Y397), cellular IC50 of 1 nM. More description

Other Targets

Customized Consultation X

Your information is safe with us. * Required Fields.